A small amount of fat does not affect piperaquine exposure in patients with malaria.

A small amount of fat does not affect piperaquine exposure in patients with malaria.

Toon andere (1) versies

Dihydroartemisinin-piperaquine is a new, highly effective, and well-tolerated combination treatment for uncomplicated falciparum malaria. The lipophilic characteristic of piperaquine suggests that administration together with fat will increase the oral bioavailability of the drug, and this has been...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Annerberg, A, Lwin, K, Lindegardh, N, Khrutsawadchai, S, Ashley, E, Day, N, Singhasivanon, P, Tarning, J, White, N, Nosten, F
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2011

Gelijkaardige items

A small amount of fat does not affect piperaquine exposure in patients with malaria.
door: Annerberg, A, et al.
Gepubliceerd in: (2011)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2014)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
door: Ashley, E, et al.
Gepubliceerd in: (2010)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
door: Ashley, E, et al.
Gepubliceerd in: (2010)

Pitfalls in estimating piperaquine elimination.
door: Tarning, J, et al.
Gepubliceerd in: (2005)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
door: Tarning, J, et al.
Gepubliceerd in: (2007)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
door: Tarning, J, et al.
Gepubliceerd in: (2008)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
door: Lwin, K, et al.
Gepubliceerd in: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
door: Lwin, K, et al.
Gepubliceerd in: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
door: Tarning, J, et al.
Gepubliceerd in: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
door: Tarning, J, et al.
Gepubliceerd in: (2014)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
door: Phyo, A, et al.
Gepubliceerd in: (2011)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
door: Rijken, M, et al.
Gepubliceerd in: (2011)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
door: Bergstrand, M, et al.
Gepubliceerd in: (2014)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.
door: Lindegardh, N, et al.
Gepubliceerd in: (2008)

Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
door: Tarning, J, et al.
Gepubliceerd in: (2006)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
door: Adam, I, et al.
Gepubliceerd in: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
door: Zongo, I, et al.
Gepubliceerd in: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
door: Adam, I, et al.
Gepubliceerd in: (2012)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
door: Hoglund, R, et al.
Gepubliceerd in: (2012)

Quantification of the antimalarial piperaquine in plasma.
door: Tarning, J, et al.
Gepubliceerd in: (2008)

A RANDOMISED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF TWO DIFFERENT DOSING REGIMENS OF DIHYDROARTEMISININ-PIPERAQUINE FOR INTERMITTENT PREVENTIVE TREATMENT OF ADULTS AT HIGH RISK OF MALARIA IN THAILAND
door: Lwin, K, et al.
Gepubliceerd in: (2010)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
door: Tarning, J, et al.
Gepubliceerd in: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
door: Tarning, J, et al.
Gepubliceerd in: (2008)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
door: Mytton, O, et al.
Gepubliceerd in: (2007)

Characterization of human urinary metabolites of the antimalarial piperaquine.
door: Tarning, J, et al.
Gepubliceerd in: (2006)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2009)

Efficacy and safety of dihydroartemisinin-piperaquine.
door: Myint, H, et al.
Gepubliceerd in: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
door: Issaka Zongo, et al.
Gepubliceerd in: (2014-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
door: Hoglund Richard M, et al.
Gepubliceerd in: (2012-11-01)

How much fat is necessary to optimize lumefantrine oral bioavailability?
door: Ashley, E, et al.
Gepubliceerd in: (2007)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
door: Smithuis, F, et al.
Gepubliceerd in: (2006)

Population pharmacokinetic properties of Piperaquine in Falciparum Malaria: an individual participant data-level meta-analysis
door: Hoglund, R, et al.
Gepubliceerd in: (2017)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
door: Rijken, M, et al.
Gepubliceerd in: (2007)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
door: Chotsiri, P, et al.
Gepubliceerd in: (2019)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
door: Awab, G, et al.
Gepubliceerd in: (2010)